Page last updated: 2024-10-31

methyl salicylate and Lupus Erythematosus, Systemic

methyl salicylate has been researched along with Lupus Erythematosus, Systemic in 1 studies

methyl salicylate: used in over-the-counter liniments, ointments, lotions for relief of musculoskeletal aches and pains; has hemolytic effect on human & sheep erythrocytes; RN given refers to parent cpd; structure in Merck Index, 9th ed, #5990
methyl salicylate : A benzoate ester that is the methyl ester of salicylic acid.

Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, YY1
Yan, Y2
Zhang, HF1
Lin, YH1
Chen, YC1
Wu, P1
Fang, JS1
Yang, SH1
Du, GH1

Other Studies

1 other study available for methyl salicylate and Lupus Erythematosus, Systemic

ArticleYear
Methyl salicylate 2-
    Drug design, development and therapy, 2016, Volume: 10

    Topics: Animals; Autoantibodies; Cytokines; Disease Progression; Female; Glycosides; Inflammation; Lupus Ery

2016